Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Clemens, J.
Right arrow Articles by Holmgren, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Clemens, J.
Right arrow Articles by Holmgren, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

American Journal of Epidemiology Vol. 142, No. 7: 759-764
Copyright © 1995 by The Johns Hopkins University School of Hygiene and Public Health


other

Impaired Immune Response to Natural Infection as a Correlate of Vaccine Failure in a Field Trial of Killed Oral Cholera Vaccines

J. Clemens1,2, M. Rao1,2, D. Sack1,3, F. Ahmed1,2, M. R. Khan1, J. Chakraborty1, B. Kay1,3,4, S. Huda1, M. Yunus1, F. van Loon1,4, A. M. Svennerholm5 and J. Holmgren5

1International Centre for Diarrheoal Disease Research Bangladesh, Dhaka, Bangladesh.
2National Institute of Child Health and Human Development Bethesda, MD.
3The Johns Hopkins School of Public Health Baltimore, MD.
4Centers for Disease Control and Prevention Atlanta, GA.
5University of Goteborg Goteborg, Sweden.

In a field trial carried out in 1985 in Matlab, Bangladesh, the authors evaluated whether subjects who developed Vibrio cholerae 01 infections during the first year after earlier receipt of B subunit-killed whole cell (BS-WC) or killed whole cell-only (WC) oral cholera vaccines exhibited deficient serum vibriocidal immune responses to these infections. After severe V. cholerae 01 infections (n = 70) in subjects < 5 years of age, the age group in which both vaccines were efficacious, a 6.5 geometric mean-fold rise of serum vibriocidal antibodies was observed among vaccinees, compared with an 18.6 geometric mean-fold rise in placeborecipients (p > 0.01). Depressions of serum vibriocidal responses among vaccinees were even more marked after asymptomatic infections (n = 30): a 1.1 geometric mean-fold rise in vaccinees versus a 5.9 geometric mean-fold rise in placebo-recipients (p < 0.01). The authors conclude that subjects who failed to be protected by BS-WC and WC, despite being in the age group for which these vaccines were protective, exhibited poor immune responses even to the vigorous stimulus of natural infection. These findings raise the possibility that immune hyporesponsiveness may limit the potential efficacy attainable by cholera vaccines in populations with endemic cholera. Am J Epidemiol 1995;142:759–64.

cholera;; cholera vaccine;; seroepidemiologic methods


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Infect. Immun.Home page
T. Ahmed, A. Lundgren, M. Arifuzzaman, F. Qadri, S. Teneberg, and A.-M. Svennerholm
Children with the Le(a+b-) Blood Group Have Increased Susceptibility to Diarrhea Caused by Enterotoxigenic Escherichia coli Expressing Colonization Factor I Group Fimbriae
Infect. Immun., May 1, 2009; 77(5): 2059 - 2064.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
F. Qadri, A. Saha, T. Ahmed, A. Al Tarique, Y. A. Begum, and A.-M. Svennerholm
Disease Burden Due to Enterotoxigenic Escherichia coli in the First 2 Years of Life in an Urban Community in Bangladesh
Infect. Immun., August 1, 2007; 75(8): 3961 - 3968.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.